Infliximab for uveitis of Behçet's syndrome: a trend for earlier initiation.

导出 LinkOut

翻译打印收藏纠错

第一作者： Gul,Guzelant

第一单位： Division of Rheumatology, Department of Internal Medicine, Cerrahpasa Medical School, Istanbul University, Istanbul, Turkey.

作者： Gul,Guzelant ^[1] ; Didar,Ucar ^[2] ; Sinem Nihal,Esatoglu ^[1] ; Gulen,Hatemi ^[1] ; Yilmaz,Ozyazgan ^[2] ; Sebahattin,Yurdakul ^[1] ; Emire,Seyahi ^[1] ; Hasan,Yazici ^[1] ; Vedat,Hamuryudan ^[3]

作者单位： Division of Rheumatology, Department of Internal Medicine, Cerrahpasa Medical School, Istanbul University, Istanbul, Turkey. ^[1] Department of Ophthalmology, Cerrahpasa Medical School, Istanbul University, Istanbul, Turkey. ^[2] Division of Rheumatology, Department of Internal Medicine, Cerrahpasa Medical School, Istanbul University, Istanbul, Turkey. vhamuryudan@yahoo.com. ^[3]

主题词成年人(Adult);消炎药(Anti-Inflammatory Agents);贝赫切特综合征(Behcet Syndrome);用药计划表(Drug Administration Schedule);女(雌)性(Female);人类(Humans);男(雄)性(Male);回顾性研究(Retrospective Studies);疾病严重程度指数(Severity of Illness Index);时间因素(Time Factors);治疗结果(Treatment Outcome);葡萄膜炎(Uveitis);视敏度(Visual Acuity)

PMID 29148418

发布时间 2018-02-13

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Clinical and experimental rheumatology

86-89页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Infliximab for uveitis of Behçet's syndrome: a trend for earlier initiation.

Clinical and experimental rheumatology

相似文献

Clinical and experimental rheumatology

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Infliximab for uveitis of Behçet's syndrome: a trend for earlier initiation.

Clinical and experimental rheumatology

相似文献

Clinical and experimental rheumatology

相关期刊

检索历史清除